Comparative efficacy of exercise modalities for cardiopulmonary function in hemodialysis patients: a systematic review and network meta-analysis
W Zang, M Fang, H He, L Mu, X Zheng, H Shu… - Frontiers in Public …, 2022 - frontiersin.org
Background To provide reliable evidence to exercise rehabilitation therapists and clinicians,
we compared and analyzed the effects of different exercise modalities on cardiopulmonary …
we compared and analyzed the effects of different exercise modalities on cardiopulmonary …
The role of mitochondrial and redox alterations in the skeletal myopathy associated with chronic kidney disease
Significance: An estimated 700 million people globally suffer from chronic kidney disease
(CKD). In addition to increasing cardiovascular disease risk, CKD is a catabolic disease that …
(CKD). In addition to increasing cardiovascular disease risk, CKD is a catabolic disease that …
Sodium-glucose cotransporter-2 inhibition for heart failure with preserved ejection fraction and chronic kidney disease with or without type 2 diabetes mellitus: a …
RJ Mentz, SA Brunton, J Rangaswami - Cardiovascular diabetology, 2023 - Springer
Background Heart failure (HF), chronic kidney disease (CKD), and type 2 diabetes mellitus
(T2DM) are common and interrelated conditions, each with a significant burden of disease …
(T2DM) are common and interrelated conditions, each with a significant burden of disease …
Changes in the cardiovascular risk profile in children approaching kidney replacement therapy
P Khandelwal, J Hofstetter, K Azukaitis, A Bayazit… - …, 2024 - thelancet.com
Background Despite significant cardiovascular (CV) morbidity in children on dialysis and
after kidney transplantation, data on the evolution of CV damage in children with chronic …
after kidney transplantation, data on the evolution of CV damage in children with chronic …
Phosphate and coronary artery disease in patients with chronic kidney disease
H Ogata, H Sugawara, M Yamamoto… - Journal of Atherosclerosis …, 2024 - jstage.jst.go.jp
Cardiovascular disease (CVD) is the leading cause of death in patients with chronic kidney
disease (CKD). Both traditional and CKD-related factors are associated with CVD in CKD …
disease (CKD). Both traditional and CKD-related factors are associated with CVD in CKD …
Pericyte loss initiates microvascular dysfunction in the development of diastolic dysfunction
SJ Simmonds, MOJ Grootaert, I Cuijpers… - … heart journal open, 2024 - academic.oup.com
Aims Microvascular dysfunction has been proposed to drive heart failure with preserved
ejection fraction (HFpEF), but the initiating molecular and cellular events are largely …
ejection fraction (HFpEF), but the initiating molecular and cellular events are largely …
[HTML][HTML] Decline in left ventricular early systolic function with worsening kidney function in children with chronic kidney disease: insights from the 4C and HOT-KID …
H Gu, K Azukaitis, A Doyon, S Erdem, B Ranchin… - Journal of the American …, 2024 - Elsevier
Introduction Adults with childhood-onset chronic kidney disease (CKD) have an increased
risk of cardiovascular disease. First-phase ejection fraction (EF1), a novel measure of early …
risk of cardiovascular disease. First-phase ejection fraction (EF1), a novel measure of early …
[HTML][HTML] Long-term changes in cardiac remodelling in prevalent kidney graft recipients
V Panisset, N Girerd, E Bozec, Z Lamiral… - International Journal of …, 2024 - Elsevier
Background Approximately 15% of kidney transplant (KT) recipients develop de novo heart
failure after KT. There are scarce data reporting the long-term changes in cardiac structure …
failure after KT. There are scarce data reporting the long-term changes in cardiac structure …
Saikosaponin A protects against uremic toxin indole‑3 acetic acid‑induced damage to the myocardium
C Chen, X Hu, X Chen - Molecular Medicine Reports, 2023 - spandidos-publications.com
Chronic kidney disease (CKD)‑associated cardiac injury is a common complication in
patients with CKD. Indole‑3 acetic acid (IAA) is a uremic toxin that injures the cardiovascular …
patients with CKD. Indole‑3 acetic acid (IAA) is a uremic toxin that injures the cardiovascular …
Implications of uremic cardiomyopathy for the practicing clinician: an educational review
H Hiraiwa, D Kasugai, T Okumura, T Murohara - Heart Failure Reviews, 2023 - Springer
Studies over recent years have redeveloped our understanding of uremic cardiomyopathy,
defined as left ventricular hypertrophy, congestive heart failure, and associated cardiac …
defined as left ventricular hypertrophy, congestive heart failure, and associated cardiac …